Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Adrian Haigh is recorded as COO at Fennec Pharmaceuticals Inc. (FENC). Fennec Pharmaceuticals Inc. reported in an 8-K filed July 2, 2024 that Adrian Haigh resigned as Chief Operating Officer, effective June 30, 2024. Fennec Pharmaceuticals Inc. reported in an 8-K filed August 4, 2023 that Adrian Haigh was appointed Chief Operating Officer, effective August 3, 2023. Adrian Haigh has spoken on 3 earnings calls across 1 company, most recently for Fennec Pharmaceuticals Inc. on May 14, 2024.
“On June 30, 2024, Adrian Haigh departed from his position as Fennec Pharmaceuticals Inc.'s (the "Company") Chief Operating Officer, a role Mr. Haigh transitioned to in August 2023 after serving nine years as an independent director of the Company.”
“Adrian has been a board member of Fennec since 2014 and with his appointment to the management team of Fennec will step down as board member.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2023-08-03–present
Start not stated–2024-06-30
Recorded roles and call appearances connecting this person to public companies.
COO
2023-08-03–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
